Evidence map›Paper›PMID 38936775›Full record

ArticleMolecular & cellular proteomics : MCP2024

Proximity Labeling Proteomics Reveals Kv1.3 Potassium Channel Immune Interactors in Microglia.

Christine A Bowen, Hai M Nguyen, Young Lin, Pritha Bagchi, Aditya Natu, Claudia Espinosa-Garcia, Erica Werner, Rashmi Kumari, Amanda Dabdab Brandelli, Prateek Kumar and 6 more

Abstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Identification of Novel Kv1.3 Channel-Interacting Proteins Using Proximity Labelling in T-Cells.Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology · 2025
    Article
  7. Article
  8. Review
  9. Progress toward a comprehensive brain protein interactome.Biochemical Society transactions · 2025
    Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Christine A BowenCenter for Neurodegenerative Diseases, Emory University, Atlanta, Georgia, USA; Department of Biochemistry, Emory University, Atlanta, Georgia, USA.
Hai M NguyenDepartment of Pharmacology, University of California - Davis, Davis, California, USA.
Young LinCenter for Neurodegenerative Diseases, Emory University, Atlanta, Georgia, USA; Department of Biochemistry, Emory University, Atlanta, Georgia, USA.
Pritha BagchiDepartment of Biochemistry, Emory University, Atlanta, Georgia, USA; Emory Integrated Proteomics Core, Emory University, Atlanta, Georgia, USA.
Aditya NatuDepartment of Human Genetics, Emory University, Atlanta, Georgia, USA.
Claudia Espinosa-GarciaSchool of Medicine, Yale University, New Haven, Connecticut, USA.
Erica WernerDepartment of Cell Biology, Emory University, Atlanta, Georgia, USA.
Rashmi KumariSchool of Medicine, Yale University, New Haven, Connecticut, USA.
Amanda Dabdab BrandelliSchool of Medicine, Yale University, New Haven, Connecticut, USA.
Prateek KumarSchool of Medicine, Yale University, New Haven, Connecticut, USA.
Brendan R TobinSchool of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA.
Levi WoodGeorge W. Woodruff School of Mechanical Engineering, Wallace H. Coulter Department of Biomedical Enigneering, and Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, Georgia, USA.
Victor FaundezDepartment of Cell Biology, Emory University, Atlanta, Georgia, USA.
Heike WulffDepartment of Pharmacology, University of California - Davis, Davis, California, USA.
Nicholas T SeyfriedCenter for Neurodegenerative Diseases, Emory University, Atlanta, Georgia, USA; Department of Biochemistry, Emory University, Atlanta, Georgia, USA.
Srikant RangarajuCenter for Neurodegenerative Diseases, Emory University, Atlanta, Georgia, USA; School of Medicine, Yale University, New Haven, Connecticut, USA. Electronic address: Srikant.rangaraju@yale.edu.

Funding

Neuron and microglia-specific proteomic signatures of ERK mediated mechanisms of Alzheimer’s diseaseR01AG075820 · NIA · YALE UNIVERSITY · PI RANGARAJU, SRIKANT, SEYFRIED, NICHOLAS THOMAS · 2021 to 2025
$5.1M
Targeting Kv1.3 potassium channels for neuro-immunomodulation in Alzheimer's DiseaseR01NS114130 · NINDS · YALE UNIVERSITY · PI RANGARAJU, SRIKANT · 2020 to 2024
$3.1M
Training Program in Biochemistry, Cell and Molecular BiologyT32GM135060 · NIGMS · EMORY UNIVERSITY · PI Lawrence H. Boise, ANITA H. CORBETT · 2020 to 2026
$2.8M
Neuronal Mechanisms of Copper Transport and ToxicityRF1AG060285 · NIA · EMORY UNIVERSITY · PI FAUNDEZ, VICTOR · 2018 to 2021
$2.4M
T32 CTEng (Cellular and Tissue Engineering) Training ProgramT32GM145735 · NIGMS · GEORGIA INSTITUTE OF TECHNOLOGY · PI Edward A. Botchwey, Andres J Garcia · 2022 to 2026
$2.3M
Microglia-specific proteomic mechanisms and biomarkers of neuroinflammation in Alzheimer’s diseaseR01AG071587 · NIA · YALE UNIVERSITY · PI RANGARAJU, SRIKANT · 2024 to 2025
$1.5M
Mitochondrial mechanisms and signaling in manganese exposureR01ES034796 · NIEHS · EMORY UNIVERSITY · PI AVANTI GOKHALE, Erica Marlis Werner · 2023 to 2026
$1.4M
Microglial K+ Channels in Ischemic StrokeR01NS100294 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI WULFF, HEIKE · 2017 to 2020
$1.3M
Regulation of Microglial Bioenergetics and Neuroinflammation by Kv1.3 Channels in Alzheimer's DiseaseF31AG074665 · NIA · EMORY UNIVERSITY · PI BOWEN, CHRISTINE ALYSSIA · 2021 to 2023
$140k
NIA NIH HHS F31 AG074665NIA NIH HHS R01 AG071587NIA NIH HHS R01 AG075820NIA NIH HHS RF1 AG060285NIEHS NIH HHS R01 ES034796NIGMS NIH HHS T32 GM135060NIGMS NIH HHS T32 GM145735NINDS NIH HHS R01 NS100294NINDS NIH HHS R01 NS114130
6 · The paper itself

Abstract

Microglia are resident immune cells of the brain and regulate its inflammatory state. In neurodegenerative diseases, microglia transition from a homeostatic state to a state referred to as disease-associated microglia (DAM). DAM express higher levels of proinflammatory signaling molecules, like STAT1 and TLR2, and show transitions in mitochondrial activity toward a more glycolytic response. Inhibition of Kv1.3 decreases the proinflammatory signature of DAM, though how Kv1.3 influences the response is unknown. Our goal was to identify the potential proteins interacting with Kv1.3 during transition to DAM. We utilized TurboID, a biotin ligase, fused to Kv1.3 to evaluate potential interacting proteins with Kv1.3 via mass spectrometry in BV-2 microglia following TLR4-mediated activation. Electrophysiology, Western blotting, and flow cytometry were used to evaluate Kv1.3 channel presence and TurboID biotinylation activity. We hypothesized that Kv1.3 contains domain-specific interactors that vary during a TLR4-induced inflammatory response, some of which are dependent on the PDZ-binding domain on the C terminus. We determined that the N terminus of Kv1.3 is responsible for trafficking Kv1.3 to the cell surface and mitochondria (e.g., NUDC, TIMM50). Whereas, the C terminus interacts with immune signaling proteins in a lipopolysaccharide-induced inflammatory response (e.g., STAT1, TLR2, and C3). There are 70 proteins that rely on the C-terminal PDZ-binding domain to interact with Kv1.3 (e.g., ND3, Snx3, and Sun1). Furthermore, we used Kv1.3 blockade to verify functional coupling between Kv1.3 and interferon-mediated STAT1 activation. Overall, we highlight that the Kv1.3 potassium channel functions beyond conducting the outward flux of potassium ions in an inflammatory context and that Kv1.3 modulates the activity of key immune signaling proteins, such as STAT1 and C3.

Indexed as

Kv1.3 Potassium ChannelMicrogliaProteomicsSTAT1 Transcription FactorToll-Like Receptor 4AnimalsCell LineLipopolysaccharidesMiceProtein BindingToll-Like Receptor 2Kv1.3 Potassium ChannelLipopolysaccharidesStat1 protein, mouseSTAT1 Transcription FactorTlr4 protein, mouseToll-Like Receptor 2Toll-Like Receptor 4Kv1.3 potassium channelmicroglianeurodegenerationneuroinflammationproximity labeling

Identifiers

PMID38936775
PMCPMC11780389

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.